[68Ga]Ga-PSMA-11, the first PSMA tracer introduced clinically in 2012 and 2013, respectively, showed a clear superiority to PET tracers such as 18Fluor(18F)-choline, which were the previous standard, by combining the high affinity to PSMA-expressing PCa cells with the high spatial resolution of PET and with a fast blood clearance, resulting in a high image contrast [6,7]. Here, FOLH1 is linked to posterior cortical atrophy.